Marc Feldmann - Dec 28, 2023 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Role
Director
Signature
/s/ Sir Marc Feldmann, Ph.D.
Stock symbol
ATNF
Transactions as of
Dec 28, 2023
Transactions value $
$0
Form type
4
Date filed
12/28/2023, 06:42 PM
Previous filing
Dec 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATNF Common Stock Award $0 +135K +117.21% $0.00 251K Dec 28, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted to the Reporting Person pursuant to the Issuer's equity compensation plans in consideration for services rendered. Exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3.